VITAMINS
Online ISSN : 2424-080X
Print ISSN : 0006-386X
Pharmacological Studies on Riboflavin Derivatives : (IV) GENERAL PHARMACOLOGICAL PROPERTIES OF 2', 3'-DI-o-NICOTINOYL RIBOFLAVIN-4'(5')-PHOSPHATE
Teruo SAITOKentaro KOGITadashi ISHIDAKazuyoshi KATUBE
Author information
JOURNAL FREE ACCESS

1974 Volume 48 Issue 5-6 Pages 229-236

Details
Abstract
2', 3'-Di-o-nicotinoyl riboflavin-4'(5')-phosphate (DNRP) caused a pharmacological action at relatively large dose. (1) Acute toxity of DNRP was studied in mice and rats (see TABLE 1). (2) DNRP decreased spontaneous motor activity in mouse (200〜300mg/kg, i.p.), rat (200〜300mg/kg, i.p.), and dog (50〜100mg/kg, i.v.). (3) DNRP (50mg/kg, s.c.) prolonged the sleeping time of pentobarbital sodium in mouse (40mg/kg, i.p.), but did not show analgesic effect. (4) DNRP (0.15〜0.3%) showed the more effective local anesthetic action than procaine did. (5) DNRP (50mg/kg, s.c.) inhibited the passage of charcoal meal through intestine. (6) DNRP decreased the tonus of isolated rabbit intestine and inhibited the spontaneous movement of isolated rat uterus. (7) DNRP depressed (nonspecifically) the contractive response of guinea pig ileum and rat uterus induced by acetylcholine, histamine, serotonine (5HT), BaCl_2,angiotensin and bradykinin. (8) DNRP potentiated the contractive response of isolated guinea pig vas deferens induced by tyramine, ephedrine, norepinephrine, epinephrine and phenylephrine.
Content from these authors
© 1974 THE VITAMIN SOCIETY OF JAPAN

この記事はクリエイティブ・コモンズ [表示 - 非営利 - 改変禁止 4.0 国際]ライセンスの下に提供されています。
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.ja
Previous article Next article
feedback
Top